Media coverage about Analogic (NASDAQ:ALOG) has trended somewhat positive recently, according to Accern. The research group scores the sentiment of press coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Analogic earned a coverage optimism score of 0.21 on Accern’s scale. Accern also assigned press coverage about the medical research company an impact score of 44.7531616587051 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
These are some of the media headlines that may have impacted Accern’s scoring:
- Altaris Capital closes $1B Analogic buyout (massdevice.com)
- Critical Analysis: Data I/O (DAIO) and Analogic (ALOG) (americanbankingnews.com)
- Data I/O (DAIO) and Analogic (ALOG) Head-To-Head Survey (americanbankingnews.com)
- Analogic’s $1B go-private sale wins shareholder approval (smartbrief.com)
- Analogic Announces Completion of Acquisition by an Affiliate of Altaris Capital Partners (streetinsider.com)
Analogic remained flat at $$83.95 on Monday, according to Marketbeat.com. 212,601 shares of the company traded hands, compared to its average volume of 216,896. The stock has a market cap of $1.05 billion, a price-to-earnings ratio of 48.81, a PEG ratio of 2.84 and a beta of 0.64. Analogic has a 12 month low of $67.85 and a 12 month high of $101.80.
ALOG has been the subject of several recent research reports. TheStreet lowered shares of Analogic from a “b-” rating to a “c” rating in a report on Monday, May 14th. BidaskClub lowered shares of Analogic from a “strong-buy” rating to a “buy” rating in a report on Tuesday, June 19th. ValuEngine lowered shares of Analogic from a “buy” rating to a “hold” rating in a report on Thursday, April 12th. Finally, Zacks Investment Research raised shares of Analogic from a “hold” rating to a “strong-buy” rating and set a $108.00 price target for the company in a report on Thursday, March 8th. Three investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $94.00.
Analogic Company Profile
Analogic Corporation designs, manufactures, and sells medical imaging systems, ultrasound and security systems, and subsystems to original equipment manufacturers (OEMs) and end users primarily for the medical and airport security markets worldwide. It operates in three segments: Medical Imaging, Ultrasound, and Security and Detection.
Receive News & Ratings for Analogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic and related companies with MarketBeat.com's FREE daily email newsletter.